Research programme: CNS therapeutics - Tridem Bioscience
Latest Information Update: 16 Mar 2023
At a glance
- Originator Tridem Bioscience
- Class Conjugate vaccines; Peptide vaccines; Synthetic vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research CNS disorders
Most Recent Events
- 16 Mar 2023 Early research in CNS disorders in Austria (Intradermal) before March 2023 (Tridem Bioscience pipeline, March 2023)